To compare the efficacy of Dexmedetomidine added to Ropivacaine in USG guided suprainguinal fascia iliaca block for peri-operative pain management in patients of trochanteric fractures.

To evaluate the clinical efficacy of Dexmedetomidine as an adjuvant to Ropivacaine in USG guided suprainguinal fascia iliaca block for peri-operative analgesia in patients of trochanteric fractures. - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/076011

Enrollment

Registered

2024-10-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexmedetomidine with ropivacaine: 28ml of 0.25%ropivacaine with 0.5microgram/ kg in USG guided suprainguinal fascia iliaca block .The total duration of the study will be 12 months Contr

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA PS I TO III 2. BMI 18.5 -29.9 3. Patients with trochanteric fracture who will be scheduled to undergo fixation of fracture ( intertrochanteric and subtrochanteric ) under spinal anaesthesia.

Exclusion criteria

Exclusion criteria: 1. patients refusal to participate in study 2. patients with anatomical spinal deformities. 3. patient with bleeding disorders and raised intracranial pressure. 4. patient with local infection at the sites where needle for spinal is to be inserted and altered anatomy like inguinal hernia, and femoral artery graft. 5. patients with dysrhythmias. 6. patients allergic to study drugs. 7. patients on anticoagulants, polytrauma. 8. failure of soinal anesthesia. 9. trochanteric femoral fractures associated with other fractures .

Design outcomes

Primary

Measure	Time frame
VAS at rest and on passive external rotation of the limb 20 minutes after the block and EOSP.Timepoint: 20 minutes	—

Secondary

Measure	Time frame
total duration of analgesia amount of tramadol used patient satisfaction score Timepoint: 6 hours,12 hours,24 hours	—

Countries

India

Contacts

Public ContactDr Nanish Sharma

Dr RPGMC TANDA Kangra Himachal Pradesh

nanish.sharma26@gmail.com8727049007

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026